The below syndicated studies are running in the US and EU5 (and Australia and India in oncology), with expansion to other APAC and MENA markets planned:
- Physician Impact Study – Oncology, MS, RA, HIV (US & EU5 data available now) Learn more about the HCP study
- Patient Impact Study – Oncology, MS, RA, IBD, Severe Asthma (US & EU5 data available now) Learn more about the Patient study
- Market Access Impact Study – National & Regional Payers Learn more about the Market Access study
A Vaccines COVID-19 impact assessment study is also available on demand.
Additionally, Ipsos has also added new questions to our longstanding syndicated Global Therapy Monitor and Global Oncology Monitor studies to enable us to understand general changes in treatment practices and patient visits as a result of COVID-19.